ARCHIVES

Cell Genesys Begins Phase II Trial Of Gvax Vaccine For Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Univ. of New Mexico Looked Over As Possible Comprehensive Center; Missouri Asks Delay

November 26, 1976

FDA News: FDA Approves Reagent System for Graft-Versus-Host Disease

January 24, 2014

Biomedical Panel To Hear Public At Sept. Meeting

July 11, 1975

NCI to release RFP for Cancer Information Service recompetition.

November 28, 2003

Clinical Cooperative Groups Asked To Develop Tamoxifen Prevention Trial; CGOPs To Participate

July 6, 1990

Upton Still Mum On Leaving; DeVita Ever More Likely as Replacement

November 30, 1979